References and Notes
For reviews, see:
1a
Hakomori S. In Sphingolipid Biochemistry. Handbook of Lipid Research
Vol. 3:
Kafner JN.
Hakomori S.
Plenum;
New York:
1983.
p.1
1b
Merrill AH.
Sweeley CC. In Biochemistry of Lipids, Lipoproteins and Membranes
Vance DE.
Vance J.
Elsevier Science B. V.;
Amsterdam:
1996.
p.309
1c
Hannun YA.
Sphingolipid-Mediated Signal Transduction
Chapman and Hall;
New York NY:
1997.
1d
Hannum YA.
Science
1996,
274:
1855
1e
Spiegel S.
Milstein S.
J. Membr. Biol.
1995,
146:
225
1f
Shayman JA.
J. Am. Soc. Nephrol.
1996,
7:
171
1g
Igarashi Y.
J. Biochem. (Tokyo)
1997,
122:
1080
1h
Ariga T.
Jarvis WD.
Yu RK.
J. Lipid. Res.
1998,
39:
1
2a
Hannun YA.
Loomis CR.
Merrill AH.
Bell RM.
J. Biol. Chem.
1986,
261:
2604
2b
Hannun YA.
Science
1989,
243:
500
3a
Nugent TC.
Hudlicky T.
J. Org. Chem.
1998,
63:
510
3b
Kobayashi S.
Furuta T.
Hayashi T.
Nishijima M.
Hanada K.
J. Am. Chem. Soc.
1998,
120:
908
3c
Mandala SM.
Harris GH.
Methods Enzymol.
2000,
311:
335
4a
VanMiddlesworth F.
Dufresne C.
Wincott FE.
Mosley RT.
Wilson KE.
Tetrahedron Lett.
1992,
33:
297
4b
VanMiddlesworth F.
Giacobbe RA.
Lopez M.
Garrity G.
Bland JA.
Bartizal K.
Fromtling RA.
Polishook J.
Zweerink M.
Edison AM.
Rozdilsky W.
Wilson KE.
Monaghan RL.
J. Antibiot.
1992,
45:
861
4c
Horn WS.
Smith JL.
Bills GF.
Raghoobar SL.
Helms GL.
Kurtz MB.
Marrinan JA.
Frommer BR.
Thornton RA.
Mandala SM.
J. Antibiot.
1992,
45:
1692
5a
Fujita T.
Inoue K.
Yamamoto S.
Ikumoto T.
Sasaki S.
Toyoma R.
Yoneta M.
Hoshino Y.
Okumoto T.
J. Antibiot.
1994,
47:
208
5b
Miyake Y.
Kozutsumi Y.
Nakamura S.
Fujita T.
Kawasaki T.
Biochem. Biophys. Res. Commun.
1995,
211:
396
5c For synthesis of myriocin, see: Oishi T.
Ando K.
Chida N.
Chem. Commun.
2001,
1932 ; and references cited therein
6
Zweerink MM.
Edison AM.
Wells GB.
Pinto W.
Lester RL.
J. Biol. Chem.
1992,
267:
25032 ; and references cited therein
7a
Trost BM.
Lee CB.
J. Am. Chem. Soc.
2001,
123:
12191
7b
Trost BM.
Lee CB.
J. Am. Chem. Soc.
1998,
120:
6818
8a
Wang B.
Yu X.-M.
Lin G.-Q.
Synlett
2001,
904
8b
Liu D.-G.
Wang B.
Lin G.-Q.
J. Org. Chem.
2000,
65:
9114
9a
Nakamura T.
Shiozaki M.
Tetrahedron
2002,
58:
8779
9b
Nakamura T.
Shiozaki M.
Tetrahedron Lett.
2001,
42:
2701
10
Oishi T.
Ando K.
Inomiya K.
Sato H.
Iida M.
Chida N.
Org. Lett.
2002,
4:
151
11a
Kobayashi S.
Furuta T.
Hayashi T.
Nishijima M.
Hanada K.
J. Am. Chem. Soc.
1998,
120:
908
11b
Kobayashi S.
Furuta T.
Tetrahedron
1998,
54:
10275
12
Lee K.-Y.
Oh C.-Y.
Ham W.-H.
Org. Lett.
2001,
4:
4403
13a
Sano S.
Kobayashi Y.
Kondo T.
Takebayashi M.
Maruyama S.
Fujita T.
Nagao Y.
Tetrahedron Lett.
1995,
36:
2097
13b
Payette DR.
Just G.
Can. J. Chem.
1981,
59:
269
14 The following reference provides detailed procedures for both the preparation of precursors of both 8 and its regioisomer, and the preparation of the regioisomer of compound 8 from the corresponding precursor. It should be mentioned that the synthesis of 8 was accomplished from its corresponding precursor following the same procedure. See: Qiao L.
Hu Y.
Nan F.
Powis G.
Kozikowski AP.
Org. Lett.
2000,
2:
115
For recent examples of Wittig and Horner-Wadsworth-Emmons reaction, see:
15a
List B.
Doehring A.
Fonseca MTH.
Job A.
Torres RR.
Tetrahedron
2006,
62:
476
For reviews, see:
15b
Harvey RG.
Curr. Org. Chem.
2004,
8:
303
15c
Quan L.-G.
Cha J.-K.
Chem. Phys. Lipids
2004,
128
15d
Rein T.
Vares L.
Kawasaki I.
Pedersen TM.
Norrby P.-O.
Brandt P.
Tanner D.
Phosphorus, Sulfur Silicon Relat. Elem.
1999,
144-146:
169
16a
Cardillo G.
Simone AD.
Gentilucci L.
Sabatino P.
Tomasini C.
Tetrahedron Lett.
1994,
35:
5051
16b
Trost BM.
Dake GR.
J. Org. Chem.
1997,
62:
5670
16c
Krawczyk H.
Synth. Commun.
2000,
30:
1787
17
Analytical Data of Compound 9.
Amorphous solid, [α]D
25 +15.6 (c 0.35, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.67-7.85 (m, 4 H), 7.29 (d, J = 8.2 Hz, 2 H), 6.95 (d, J = 8.4 Hz, 2 H), 4.65 (d, J = 11.0 Hz, 2 H), 4.43 (d, J = 4.1 Hz, 1 H), 4.40 (s, 3 H), 4.28 (m, 1 H), 4.19 (d, J = 10.6 Hz, 1 H), 4.07 (dd, J
1 = 10.2 Hz, J
2 = 9.0 Hz, 1 H), 3.92 (s, 3 H), 3.65 (dd, J
1 = 9.6 Hz, J
2 = 8.8 Hz, 1 H), 2.27 (d, J = 7.4 Hz, 2 H), 1.53 (s, 3 H), 1.49 (s, 3 H), 1.39 (s, 3 H), 1.34 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 171.03, 166.48, 166.50, 159.31, 158.70, 134.57, 134.45, 134.43, 133.63, 131.66, 131.38, 129.89, 129.50, 129.48, 116.45, 110.76, 110.54, 80.02, 79.89, 79.07, 76.75, 75.34, 73.36, 72.16, 71.40, 57.86, 27.33, 27.06, 26.68, 24.65. HRMS: m/z calcd for C31H35NO10: 581.2261; found: 581.2263.
18a
Paulsen H.
Heiker FR.
Angew Chem., Int. Ed. Engl.
1980,
19:
904
18b
Paulsen H.
Heiker FR.
Liebigs Ann. Chem.
1981,
2180
19
Bartlett PA.
Johnson WS.
Tetrahedron Lett.
1970,
4459
For recent examples of Barton decarboxylation, see:
20a
Masterson DS.
Porter NA.
Org. Lett.
2002,
4:
4253
20b
Elena M.
Taddei M.
Tetrahedron Lett.
2001,
42:
3519
20c For a review, see: Barton DHR.
Aldrichimica Acta
1990,
23:
3
21a
Gigg J.
Gigg R.
Payne S.
Conant R.
J. Chem. Soc., Perkin. Trans. 1
1987,
423
21b
Vacca JP.
de Solms SJ.
Huff JR.
J. Am. Chem. Soc.
1987,
109:
3478
21c
Vacca JP.
de Solms SJ.
Huff JR.
Billington BC.
Baker R.
Kulagowski JJ.
Mawer IM.
Tetrahedron
1989,
45:
5679
22
Analytical Data of Compound 12.
Amorphous solid, [α]D
25 +20.3 (c 0.15, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.70-7.88 (m, 4 H), 7.27-7.33 (m, 6 H), 6.86-6.89 (m, 4 H), 6.85 (d, J = 8.3 Hz, 2 H), 4.63-4.68 (m, 6 H), 4.40 (d, J = 3.8 Hz, 1 H), 4.29 (m, 1 H), 3.90 (d, J = 10.6 Hz, 1 H), 3.83 (2 × s, 6 H), 3.80 (s, 3 H), 3.48 (dd, J
1 = 10.6 Hz, J
2 = 10.2 Hz, 1 H), 3.45 (dd, J
1 = 10.6 Hz, J
2 = 9.8 Hz, 1 H), 1.67 (s, 3 H), 1.36 (s, 3 H), 1.33 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 166.68, 166.50, 159.31, 159.16, 157.35, 138.56, 138.45, 135.46, 135.15, 134.43, 133.10, 131.58, 131.38, 130.73, 129.89, 129.50, 128.55, 128.38, 128.37, 128.00, 127.99, 113.91, 110.89, 83.22, 81.49, 81.28, 76.50, 75.60, 71.73, 69.19, 55.63, 27.35, 25.91.
23a
Bredenkamp MW.
Holzapfel CW.
Swanepoel AD.
Tetrahedron Lett.
1990,
31:
2759
23b
David S.
Hanessian S.
Tetrahedron
1985,
41:
643
23c
Pereyre M.
Quintard J.-P.
Rahm A.
Tin in Organic Synthesis
Butterworths;
London:
1987.
p.261
24
Analytical Data of Compound 6.
Amorphous solid, [α]D
25 +8.9 (c 0.20, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.74-7.90 (m, 4 H), 7.26-7.33 (m, 6 H), 6.86-6.89 (m, 4 H), 6.85 (d, J = 8.0 Hz, 2 H), 5.31 (s, 1 H), 4.64-4.68 (m, 4 H), 4.64 (d, J = 9.6 Hz, 2 H), 3.86 (d, J = 9.2 Hz, 1 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.46 (dd, J
1 = 9.6 Hz, J
2 = 7.8 Hz, 1 H), 3.35 (br s, 1 H), 3.35 (s, 3 H), 1.66 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 165.78, 165.50, 159.31, 159.26, 139.77, 138.85, 138.46, 135.46, 135.02, 134.44, 133.20, 132.66, 131.75, 131.23, 129.89, 129.88, 128.05, 127.98, 127.85, 126.88, 110.91, 110.89, 83.63, 81.62, 81.28, 80.66, 75.81, 75.47, 74.27, 73.97, 55.23, 55.20. HRMS: m/z calcd for C40H41NO9: 679.2781; found: 679.2785.
25a
Chida N.
Yamada L.
Suzuki M.
Ogawa S.
J. Carbohydr. Chem.
1992,
11:
137
25b
Paulsen H.
Roeben W.
Liebigs Ann. Chem.
1985,
5:
974
26
Analytical Data for Compound 2 (Sphingofungin F).
Amorphous solid, [α]D
25 +1.33 (c 0.20, MeOH). 1H NMR (400 MHz, CD3OD): δ = 5.78 (dt, J
1 = 15.6 Hz, J
2 = 6.6 Hz, 1 H), 5.46 (dd, J
1 = 15.5 Hz, J
2 = 8.0 Hz, 1 H), 4.11 (t, J = 7.6 Hz, 1 H), 3.86 (br s, 1 H), 3.67 (d, J = 7.5 Hz, 1 H), 2.45 (t, J = 7.5 Hz, 4 H), 2.04-2.06 (m, 2 H), 1.49-1.56 (m, 4 H), 1.48 (s, 3 H), 1.26-1.43 (m, 12 H), 0.90 (t, J = 6.7 Hz, 3 H). 13C NMR (100 MHz, CD3OD): δ = 214.53, 175.32, 135.75, 130.30, 76.25, 75.73, 72.44, 67.03, 43.50, 33.52, 32.79, 30.26, 30.03, 25.02, 23.67, 21.80, 14.43.